Medical and Biotech research firms are getting a lot closer to bringing Cannabinoid, or CBD remedies into the main stream. CBD's as they are known, may have significant therapeutic and even healing properties and companies are spending a lot of money to bet on that future promise. [18:42] Eric Adams is the CEO of InMed Pharmaceuticals. He joins the friends live to discuss a recent FDA approval and what it means for CBD researchers.